https://m2.mtmt.hu/ hun 2026-03-09 01:40 JournalArticle 33623361 VALIDATED true Funding Agency and Grant Number: Hungarian National Research, Development and Innovation Office [FK132251, ANN139112, TKP2021-EGA-29, KKP129954, TKP2021-EGA-24]; European Union [UNKP-21-5-SE-2]; Lendules~program of the Hungarian Academy of Sciences; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund; [777357]; [LP2022-14/2022] Funding text: We thank Nikolett Szenasi for expert technical assistance; Eszter Boglarka Kovacs, Akos Maklari, and Krisztina Futosi for help with experiments; Emmanuelle Passegue & nbsp;and Alexander Tarakhovsky for transgenic animals and Miklos & nbsp;Sardy for providing human skin samples. This work was funded and supported by the Hungarian National Research, Development and Innovation Office (FK132251, ANN139112, and TKP2021-EGA-29 to TN; KKP129954, TKP2021-EGA-24, and TKP2021-EGA-29 to AM) , the European Union's IMI2 programme (RTCure project number 777357 to AM) , the Lendules & nbsp;program of the Hungarian Academy of Sciences (LP2022-14/2022 to TN) , the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to TN) , and the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund (number UNKP-21-5-SE-2 to TN) . 0 false 2026-01-26T11:37:07.620+0000 2025-09-09T07:51:01.743+0000 2023-02-06T09:03:25.854+0000 true 10026589 Tichy Rita /api/admin/10026589 Admin Tichy Rita (SE_KK_Admin5_TR, admin) true 10026589 2026-01-23T15:11:43.950+0000 2025-08-05T10:57:49.522+0000 true 10062062 Gere Tamásné /api/admin/10062062 Admin Gere Tamásné (SE_KK_Admin5_GT, admin) true 10062062 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Németh, Tamás true true /api/journal/2590 REVIEWED JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 true false 2590 false 2590 true 0022-202X 1523-1747 Journal FOREIGN 143 7 1147 1156 1147 10 2023 Funding 2026052 /api/funding/2026052 (FK132251) false true Funding 2026053 /api/funding/2026053 (ANN139112) false true Funding 2026054 /api/funding/2026054 (TKP2021-EGA-29) false true Funding 2026055 /api/funding/2026055 (KKP129954) false true Funding 2026056 /api/funding/2026056 (TKP2021-EGA-24) false true Funding 2049950 /api/funding/2049950 (777357) Támogató: RTCure false true Funding 2026058 /api/funding/2026058 (LP2022-14/2022) false true Funding 2049949 /api/funding/2049949 Bolyai János Kutatási Ösztöndíj Támogató: MTA false true Funding 2026059 /api/funding/2026059 (UNKP-21-5-SE-2) false true true true 2023 true true true false true false GOLD 2026-01-26 true https://doi.org/10.1016/j.jid.2022.12.016 4 0 4 2 2 3 4 4 4 4 4 2 2 2 2 0 4 2 4 2 0 16 16 Folyóiratcikk Journal Article 24 4 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 3 1 3 1 2025 0 1 1 1 1 D1 false 10011643,10023794 false false false 2023-05-07T08:03:39.867+0000 Belgyógyászati és Onkológiai Klinika (SE / AOK / K); MTA-SE Lendület Gyulladásélettani Kutatócsoport (SE / AOK / I / ÉI); MTA-SE Lendület Transzlációs Reumatológiai Kuta... (SE / KKP / RIK); Reumatológiai és Klinikai Immunológiai Tanszék (SE / AOK / K / BOK); Élettani Intézet (SE / AOK / I) 5 17 5 5 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 106603587 /api/authorship/106603587 Németh, Tamás ✉ [Németh, Tamás (élettan), szerző] Élettani Intézet (SE / AOK / I); MTA-SE Lendület Gyulladásélettani Kutatócsoport (SE / AOK / I / ÉI); Belgyógyászati és Onkológiai Klinika (SE / AOK / K); Reumatológiai és Klinikai Immunológiai Tanszék (SE / AOK / K / BOK); MTA-SE Lendület Transzlációs Reumatológiai Kuta... (SE / KKP / RIK) 1 0.2 true false true Author 10023794 /api/author/10023794 Németh Tamás (élettan) Németh Tamás true 10023794 true Németh Tamás true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106603588 /api/authorship/106603588 Balogh, Lili [Balogh, Lili (Élettan), szerző] Élettani Intézet (SE / AOK / I); MTA-SE Lendület Transzlációs Reumatológiai Kuta... (SE / KKP / RIK) 2 0.2 false false false Author 10088503 /api/author/10088503 Balogh Lili (Élettan) Balogh Lili true true Balogh Lili true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106603589 /api/authorship/106603589 Káposztás, Eszter [Káposztás, Eszter Gertrúd (Élettan), szerző] Élettani Intézet (SE / AOK / I); MTA-SE Lendület Transzlációs Reumatológiai Kuta... (SE / KKP / RIK) 3 0.2 false false false Author 10087276 /api/author/10087276 Káposztás Eszter Gertrúd (Élettan) Káposztás Eszter Gertrúd true true Káposztás Eszter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106603590 /api/authorship/106603590 Szilveszter, Kata P. [Szilveszter, Kata (Élettan), szerző] Élettani Intézet (SE / AOK / I) 4 0.2 false false false Author 10063752 /api/author/10063752 Szilveszter Kata (Élettan) Szilveszter Kata true 10063752 true Szilveszter Kata P. true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 106603591 /api/authorship/106603591 Mócsai, Attila [Mócsai, Attila (Élettan, sejtbiol...), szerző] Élettani Intézet (SE / AOK / I) 5 0.2 false true false Author 10011643 /api/author/10011643 Mócsai Attila (Élettan, sejtbiológia) Mócsai Attila true 10011643 true Mócsai Attila true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 23025536 /api/publicationidentifier/23025536 DOI: 10.1016/j.jid.2022.12.016 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GOLD true IDENTICAL 10.1016/j.jid.2022.12.016 https://doi.org/10.1016/j.jid.2022.12.016 false true PublicationIdentifier 24246633 /api/publicationidentifier/24246633 WoS: 001032935800001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001032935800001 https://www.webofscience.com/wos/woscc/full-record/001032935800001 true true PublicationIdentifier 23423220 /api/publicationidentifier/23423220 Scopus: 85152264862 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85152264862 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85152264862 true true PublicationIdentifier 23025537 /api/publicationidentifier/23025537 PubMed: 36641133 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 36641133 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36641133&dopt=Abstract false true Classification 12215 /api/classification/12215 Klinikai orvostan true true SjrRating 11369373 /api/sjrrating/11369373 sjr:D1 (2023) Scopus - Dermatology JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 8 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2708 /api/classificationexternal/2708 Scopus - Dermatology true 2708 true D1 DIRECT true true Reference 38104702 /api/reference/38104702 1. Awan 2019: Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2 study., Leuk Lymphoma, 60, p. 1972, DOI: 10.1080/10428194.2018.1562180 1 10.1080/10428194.2018.1562180 false true Reference 38104703 /api/reference/38104703 2. Chiriac 2007: NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage., J Pathol, 212, p. 56, DOI: 10.1002/path.2157 2 10.1002/path.2157 false true Reference 38104704 /api/reference/38104704 3. Csepregi 2018: Myeloid-specific deletion of Mcl-1 yields severely neutropenic mice which survive and breed in homozygous form., J Immunol, DOI: 10.4049/jimmunol.1701803 3 10.4049/jimmunol.1701803 false true Reference 38104705 /api/reference/38104705 4. Csorba 2010: Cross-reactivity of autoantibodies from patients with epidermolysis bullosa acquisita with murine collagen VII., Cell Mol Life Sci, 67, p. 1343, DOI: 10.1007/s00018-009-0256-3 4 10.1007/s00018-009-0256-3 false true Reference 38104706 /api/reference/38104706 5. Davis 2011: Comprehensive analysis of kinase inhibitor selectivity., Nat Biotechnol, 29, p. 1046, DOI: 10.1038/nbt.1990 5 10.1038/nbt.1990 false true Reference 38104707 /api/reference/38104707 6. de Boer 2003: Transgenic mice with hematopoietic and lymphoid specific expression of Cre., Eur J Immunol, 33, p. 314, DOI: 10.1002/immu.200310005 6 10.1002/immu.200310005 false true Reference 38104708 /api/reference/38104708 7. Futosi 2012: Dasatinib inhibits proinflammatory functions of mature human neutrophils., Blood, 119, p. 4981, DOI: 10.1182/blood-2011-07-369041 7 10.1182/blood-2011-07-369041 false true Reference 38104709 /api/reference/38104709 8. Geahlen 2014: Getting Syk: spleen tyrosine kinase as a therapeutic target., Trends Pharmacol Sci, 35, p. 414, DOI: 10.1016/j.tips.2014.05.007 8 10.1016/j.tips.2014.05.007 false true Reference 38104710 /api/reference/38104710 9. Genovese 2014: A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist., J Rheumatol, 41, p. 2120, DOI: 10.3899/jrheum.140238 9 10.3899/jrheum.140238 false true Reference 38104711 /api/reference/38104711 10. Ho 2016: Inhibition of IKKα by BAY61-3606 Reveals IKKalpha-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells., PLoS One, 11, DOI: 10.1371/journal.pone.0150339 10 10.1371/journal.pone.0150339 false true Reference 38104712 /api/reference/38104712 11. Jakus 2009: Critical role of phospholipase Cγ2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis., J Exp Med, 206, p. 577, DOI: 10.1084/jem.20081859 11 10.1084/jem.20081859 false true Reference 38104713 /api/reference/38104713 12. Koga 2019: Epidermolysis Bullosa Acquisita: The 2019 Update., Front Med (Lausanne), 5, p. 362, DOI: 10.3389/fmed.2018.00362 12 10.3389/fmed.2018.00362 false true Reference 38104714 /api/reference/38104714 13. Kovács 2014: The Src-family kinases Hck, Fgr, and Lyn are critical for the generation of the in vivo inflammatory environment without a direct role in leukocyte recruitment., J Exp Med, 211, p. 1993, DOI: 10.1084/jem.20132496 13 10.1084/jem.20132496 false true Reference 38104715 /api/reference/38104715 14. Ludwig 2012: Model systems duplicating epidermolysis bullosa acquisita: a methodological review., Autoimmunity, 45, p. 102, DOI: 10.3109/08916934.2011.606451 14 10.3109/08916934.2011.606451 false true Reference 38104716 /api/reference/38104716 15. Mihai 2007: The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita., J Immunol, 178, p. 6514, DOI: 10.4049/jimmunol.178.10.6514 15 10.4049/jimmunol.178.10.6514 false true Reference 38104717 /api/reference/38104717 16. Mócsai 2006: Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs., Nat Immunol, 7, p. 1326, DOI: 10.1038/ni1407 16 10.1038/ni1407 false true Reference 38104718 /api/reference/38104718 17. Mócsai 2010: The SYK tyrosine kinase: a crucial player in diverse biological functions., Nat Rev Immunol, 10, p. 387, DOI: 10.1038/nri2765 17 10.1038/nri2765 false true Reference 38104719 /api/reference/38104719 18. Mócsai 2003: G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells., Blood, 101, p. 4155, DOI: 10.1182/blood-2002-07-2346 18 10.1182/blood-2002-07-2346 false true Reference 38104720 /api/reference/38104720 19. Mócsai 2002: Syk is required for integrin signaling in neutrophils., Immunity, 16, p. 547, DOI: 10.1016/S1074-7613(02)00303-5 19 10.1016/S1074-7613(02)00303-5 false true Reference 38104721 /api/reference/38104721 20. Németh 2010: Neutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: Generation and analysis of a novel null mutation in mice., J Immunol, 185, p. 3064, DOI: 10.4049/jimmunol.0904163 20 10.4049/jimmunol.0904163 false true Reference 38104722 /api/reference/38104722 21. Németh 2016: Neutrophil-specific deletion of the CARD9 gene expression regulator suppresses autoantibody-induced inflammation in vivo., Nat Commun, 7, DOI: 10.1038/ncomms11004 21 10.1038/ncomms11004 false true Reference 38104723 /api/reference/38104723 22. Németh 2018: Lineage-Specific Analysis of Syk Function in Autoantibody-Induced Arthritis., Front Immunol, 9, p. 555, DOI: 10.3389/fimmu.2018.00555 22 10.3389/fimmu.2018.00555 false true Reference 38104724 /api/reference/38104724 23. Németh 2016: Feedback amplification of neutrophil function., Trends Immunol, 37, p. 412, DOI: 10.1016/j.it.2016.04.002 23 10.1016/j.it.2016.04.002 false true Reference 38104725 /api/reference/38104725 24. Németh 2017: The Syk tyrosine kinase is required for skin inflammation in an in vivo mouse model of epidermolysis bullosa acquisita., J Invest Dermatol, 137, p. 2131, DOI: 10.1016/j.jid.2017.05.017 24 10.1016/j.jid.2017.05.017 false true Reference 38104726 /api/reference/38104726 25. Passegue 2004: JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells., Cell, 119, p. 431, DOI: 10.1016/j.cell.2004.10.010 25 10.1016/j.cell.2004.10.010 false true Reference 38104727 /api/reference/38104727 26. Saijo 2003: Essential role of Src-family protein tyrosine kinases in NF-κB activation during B cell development., Nat Immunol, 4, p. 274, DOI: 10.1038/ni893 26 10.1038/ni893 false true Reference 38104728 /api/reference/38104728 27. Samavedam 2018: Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita., Front Immunol, 9, p. 249, DOI: 10.3389/fimmu.2018.00249 27 10.3389/fimmu.2018.00249 false true Reference 38104729 /api/reference/38104729 28. Schmidt 2013: Pemphigoid diseases., Lancet, 381, p. 320, DOI: 10.1016/S0140-6736(12)61140-4 28 10.1016/S0140-6736(12)61140-4 false true Reference 38104730 /api/reference/38104730 29. Sharman 2015: An open-label phase 2 trial of entospletinib (GS-9973), a selective spleen tyrosine kinase inhibitor, in chronic lymphocytic leukemia., Blood, 125, p. 2336, DOI: 10.1182/blood-2014-08-595934 29 10.1182/blood-2014-08-595934 false true Reference 38104731 /api/reference/38104731 30. Sitaru 2007: Experimental models of epidermolysis bullosa acquisita., Exp Dermatol, 16, p. 520, DOI: 10.1111/j.1600-0625.2007.00564.x 30 10.1111/j.1600-0625.2007.00564.x false true Reference 38104732 /api/reference/38104732 31. Sitaru 2005: Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen., J Clin Invest, 115, p. 870, DOI: 10.1172/JCI200521386 31 10.1172/JCI200521386 false true Reference 38104733 /api/reference/38104733 32. Szilveszter 2019: Tyrosine kinases in autoimmune and inflammatory skin diseases., Front Immunol, 10, p. 1862, DOI: 10.3389/fimmu.2019.01862 32 10.3389/fimmu.2019.01862 false true Reference 38104734 /api/reference/38104734 33. Szilveszter 2021: Phospholipase Cgamma2 is Essential for Experimental Models of Epidermolysis Bullosa Acquisita., J Invest Dermatol 33 false true Reference 38104735 /api/reference/38104735 34. Tang 2022: Investigational spleen tyrosine kinase (SYK) inhibitors for the treatment of autoimmune diseases., Expert Opin Investig Drugs, 31, p. 291, DOI: 10.1080/13543784.2022.2040014 34 10.1080/13543784.2022.2040014 false true Reference 38104736 /api/reference/38104736 35. Turcan 2015: Blistering disease: insight from the hemidesmosome and other components of the dermal-epidermal junction., Cell Tissue Res, 360, p. 545, DOI: 10.1007/s00441-014-2021-7 35 10.1007/s00441-014-2021-7 false true Reference 38104737 /api/reference/38104737 36. Turner 1995: Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk., Nature, 378, p. 298, DOI: 10.1038/378298a0 36 10.1038/378298a0 false true Reference 38104738 /api/reference/38104738 37. Weber 2015: Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity., J Exp Med, 212, p. 15, DOI: 10.1084/jem.20130062 37 10.1084/jem.20130062 false true Reference 38104739 /api/reference/38104739 38. Weinblatt 2008: Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial., Arthritis Rheum, 58, p. 3309, DOI: 10.1002/art.23992 38 10.1002/art.23992 false true Reference 38104740 /api/reference/38104740 39. Weinblatt 2010: An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis., N Engl J Med, 363, p. 1303, DOI: 10.1056/NEJMoa1000500 39 10.1056/NEJMoa1000500 false true Reference 38104741 /api/reference/38104741 40. Wong 2004: Targeting Syk as a treatment for allergic and autoimmune disorders., Expert Opin Investig Drugs, 13, p. 743, DOI: 10.1517/13543784.13.7.743 40 10.1517/13543784.13.7.743 false true /api/publication/33623361 Németh Tamás et al. Neutrophil-specific Syk expression is crucial for skin disease in experimental epidermolysis bullosa acquisita. (2023) JOURNAL OF INVESTIGATIVE DERMATOLOGY 0022-202X 1523-1747 143 7 1147-1156<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10023794"><a href="/gui2/?type=authors&mode=browse&sel=10023794" target="_blank">Németh Tamás ✉ (<span class="authorship-author-name">Németh Tamás</span> <span class="authorAux-mtmt"> élettan</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Élettani Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/<span title="Élettani Intézet">ÉI</span>/MTA-SE Lendület Gyulladásélettani Kutatócsoport; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/Belgyógyászati és Onkológiai Klinika; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/Reumatológiai és Klinikai Immunológiai Tanszék; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/<span title="Reumatológiai és Klinikai Immunológiai Tanszék">RKIT</span>/MTA-SE Lendület Transzlációs Reumatológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10088503"><a href="/gui2/?type=authors&mode=browse&sel=10088503" target="_blank">Balogh Lili (<span class="authorship-author-name">Balogh Lili</span> <span class="authorAux-mtmt"> Élettan</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Élettani Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/<span title="Reumatológiai és Klinikai Immunológiai Tanszék">RKIT</span>/MTA-SE Lendület Transzlációs Reumatológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10087276"><a href="/gui2/?type=authors&mode=browse&sel=10087276" target="_blank">Káposztás Eszter (<span class="authorship-author-name">Káposztás Eszter Gertrúd</span> <span class="authorAux-mtmt"> Élettan</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Élettani Intézet; <span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Klinikum">K</span>/<span title="Belgyógyászati és Onkológiai Klinika">BOK</span>/<span title="Reumatológiai és Klinikai Immunológiai Tanszék">RKIT</span>/MTA-SE Lendület Transzlációs Reumatológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10063752"><a href="/gui2/?type=authors&mode=browse&sel=10063752" target="_blank">Szilveszter Kata P. (<span class="authorship-author-name">Szilveszter Kata</span> <span class="authorAux-mtmt"> Élettan</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Élettani Intézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10011643"><a href="/gui2/?type=authors&mode=browse&sel=10011643" target="_blank">Mócsai Attila (<span class="authorship-author-name">Mócsai Attila</span> <span class="authorAux-mtmt"> Élettan, sejtbiológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/<span title="Általános Orvostudományi Kar">AOK</span>/<span title="Intézet">I</span>/Élettani Intézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;33623361" target="_blank">Neutrophil-specific Syk expression is crucial for skin disease in experimental epidermolysis bullosa acquisita</a></div> <div> <span class="journal-title">JOURNAL OF INVESTIGATIVE DERMATOLOGY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/0022-202X">0022-202X</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1523-1747">1523-1747</a>)</span>: <span class="journal-volume">143</span> <span class="journal-issue">7</span> <span class="page"> pp 1147-1156 </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GOLD" title=" Gold "> <a style="color:blue" title="10.1016/j.jid.2022.12.016" target="_blank" href="https://doi.org/10.1016/j.jid.2022.12.016"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001032935800001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001032935800001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85152264862" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85152264862"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="36641133" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=36641133&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Dermatology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Biochemistry&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Molecular Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q1</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Cell Biology&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 4</span> | Független: 2 | Függő: 2 | Nem jelölt: 0 | WoS jelölt: 4 | Scopus jelölt:&nbsp;4 | WoS/Scopus jelölt:&nbsp;4 | DOI jelölt:&nbsp;4 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;33623361&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 16 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 33623361</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> (FK132251), (ANN139112), (TKP2021-EGA-29), (KKP129954), (TKP2021-EGA-24), (777357) Támogató: RTCure, (LP2022-14/2022), (Bolyai János Kutatási Ösztöndíj) Támogató: MTA, (UNKP-21-5-SE-2) </div> <div class="lastModified">Utolsó módosítás: 2025.09.09. 09:51 Molnár-Taga Márta (SE 4-es admin) </div> <pre class="comment" style="margin-top: 0; margin-bottom: 0;"><u>Megjegyzés</u>: Funding Agency and Grant Number: Hungarian National Research, Development and Innovation Office [FK132251, ANN139112, TKP2021-EGA-29, KKP129954, TKP2021-EGA-24]; European Union [UNKP-21-5-SE-2]; Lendules~program of the Hungarian Academy of Sciences; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; New National Excellence Program of the Ministry for Innovation and Technolo...</pre> </div></div>